Collin M Blakely
11PUBLICATIONS
230CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jun 02, 2025
Neoadjuvant Osimertinib for Resectable <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer.Jianxing He, Masahiro Tsuboi, Walter Weder
|Feb 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.Collin M Blakely, Anatoly Urisman, Matthew A Gubens
|Jun 13, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.Sebastijan Hobor, Maise Al Bakir, Crispin T Hiley
|May 03, 2024
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.Franziska Haderk, Yu-Ting Chou, Lauren Cech
Pageof 2
Frequent Collaborators
8 joint publications
Trever G Bivona
6 joint publications
D Lucas Kerr
5 joint publications
Wei Wu
3 joint publications
Ying Ni
3 joint publications
Marcelo V Negrao
3 joint publications
Matthias Scheffler
3 joint publications
Catherine A Shu
3 joint publications
Teng Zhou
3 joint publications
Jianjun Zhang
3 joint publications
Richard Lee
